Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-12-04T19:32:36.058Z Has data issue: false hasContentIssue false
  • English
  • Français

The Clinical Challenges of AIDS and HIV Infection

Published online by Cambridge University Press:  28 April 2021

Kenneth H. Mayer
Get access Rights & Permissions [Opens in a new window]

Extract

Researchers trying to resolve the questions surrounding the AIDS epidemic may feel like Hercules trying to slay the Hydra: for every head that is cut off, two new ones grow in its place. Doctors have never treated their patients in a social vacuum, but the expectations and anxieties engendered by AIDS are bringing fundamental changes in clinical p-actice. Drugs are being raced from the laboratory bench to the bedside, health care providers are being forced to recognize new types of family constellations, and the general public is being shocked into awareness of the importance of prudent infection control policies. Clinical practitioners have had to deal with the ethical consequences of routine and arcane decisions as never before, knowing that yesterday's experiment or hospital rounds can become tomorrow's lead feature in the news media.

Type
Article
Information
Law, Medicine and Healthcare , Volume 14 , Issue 5-6 , December 1986 , pp. 281 - 289
Copyright
Copyright © American Society of Law, Medicine and Ethics 1986

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Cooper, DA et al., Acute AIDS retrovirus infection: Definition of a clinical illness associated with seroconversion, Lancet 1985, i: 537–40.Google Scholar
Ho, DD et al., Primary human T-lymphotropic virus type III infection, Annals of Internal Medicine 1985, 103: 880–83.CrossRefGoogle ScholarPubMed
Lange, JMA et al., Distinct IgG recognition patterns during progression of subclinical and clinical infection with LAV/HTLV-III, British Medical Journal 1985, 292: 228–30; Goudsmit, J et al., Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection, Lancet 1986, ii: 177-80.CrossRefGoogle Scholar
Curran, JW et al., The epidemiology of AIDS: Current status and future prospects, Science 1985, 229: 1352–57.CrossRefGoogle ScholarPubMed
Jaffe, H et al., Natural history of HTLV-III/LAV infection in a cohort of gay men, in Program and abstracts of the 26th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, Louisiana, September 28-October 1, 1986.Google Scholar
Redfield, RR et al., The natural history of HTLV-III/LAV infection, in Program and abstracts of the Second International Conference on AIDS, Paris, June 23–25, 1986.Google Scholar
Mathur-Wagh, U et al., Longitudinal study of persistent generalized lymphadenopathy in homosexual men: Relation to the acquired immunodeficiency syndrome, Lancet 1984, i: 1033–38.CrossRefGoogle Scholar
Abrams, DI, Mess, TP, Volberding, P, Lymphadenopathy: Update of a 40-month prospective study; Paper presented at the International Conference on AIDS, Atlanta, Ga., April 15, 1985.Google Scholar
Goedert, JJ et al., Three year incidence of AIDS among HTLV-III infected risk group members: A comparison of five cohorts, Science 1986, 231: 992–95.CrossRefGoogle Scholar
Curran, et al., supra note 4; Jaffe, HW et al., The acquired immunodeficiency syndrome in a cohort of homosexual men: A six-year follow-up study, Annals of Internal Medicine 1985, 103: 210–14; Metroka, CE et al., Generalized lymphadenopathy in homosexual men, Annals of Internal Medicine 1983, 99: 585-91.Google Scholar
Klein, RS et al., Oral candidiasis in high risk patients as the initial manifestation of the acquired immunodeficiency syndrome, New England Journal of Medicine 1984, 311: 354–58.CrossRefGoogle ScholarPubMed
Gottlieb, MS, Fahey, JL, The clinical laboratory in the diagnosis and management of AIDS and HTLV-III/LAV infections, Plenary Session II of the Program and abstracts of the Second International Conference on AIDS, Paris, June 23–25, 1986.Google Scholar
Kovacs, JA et al., Pneumocystis carinii pneumonia: A comparison between patients with acquired immunodeficiency syndrome and patients with other immunodeficiencies, Annals of Internal Medicine 1984, 100: 663–71.CrossRefGoogle ScholarPubMed
Gordin, FM et al., Adverse reactions to trimethoprim-sulfamethoxazole in patients with AIDS, Annals of Internal Medicine 1984, 100: 495–99.CrossRefGoogle Scholar
Haverkos, HW, Assessment of therapy for Pneumocystis carinii pneumonia, American Journal of Medicine 1984, 76: 501–8.CrossRefGoogle ScholarPubMed
Hughes, WT, Smith, BC, Efficiency of diaminodiphenylsulfone and other drugs in murine Pneumocystis carinii pneumonia, Antimicrobial Agents and Chemotherapy 1984, 26: 436.CrossRefGoogle Scholar
Klein, et al., supra note 11.Google Scholar
Curran, JW et al., The epidemiology of AIDS: Current status and future prospects, Science 1985, 229: 1351–57.CrossRefGoogle ScholarPubMed
Zuger, A et al., Cryptococcal disease in patients with acquired immunodeficiency syndrome, Annals of Internal Medicine 1986, 104: 134–40.Google ScholarPubMed
Bennett, JE et al., A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis, New England Journal of Medicine 1979, 301: 126–31.CrossRefGoogle Scholar
Luft, BJ et al., Toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome, Journal of the American Medical Association 1984, 252: 913–17.Google Scholar
Wong, B et al., Central nervous system toxoplasmosis in homosexual men and parenteral drug abusers, Annals of Internal Medicine 1984, 100: 36–42.CrossRefGoogle ScholarPubMed
Soave, R et al., Cryptosporidiosis in homosexual men, Annals of Internal Medicine 1984, 100: 504–11.CrossRefGoogle ScholarPubMed
Hawkins, CC et al., Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome, Annals of Internal Medicine 1986, 105: 184–88.Google ScholarPubMed
Zakowski, P et al., Disseminated Mycobacterium avium-intracellulare infection in homosexual men dying of acquired immunodeficiency syndrome, Journal of the American Medical Association 1982, 248: 1980–82.Google Scholar
Pitchenik, AE et al., Tuberculosis, atypical mycobacteriosis and the acquired immunodeficiency syndrome among Haitian and non-Haitian patients in south Florida, Annals of Internal Medicine 1984, 101: 641–45.Google ScholarPubMed
Mintz, L et al., Cytomegalovirus infections in homosexual men: An epidemiological study, Annals of Internal Medicine 1983, 99: 326–29; Lange, M et al., Cytomegalovirus isolation from healthy homosexual men, Journal of the American Medical Association 1984, 252: 1908-10.Google ScholarPubMed
Laurence, J, AIDS report, CMV infections in AIDS patients, Infections in Surgery 1986, 603–10; Tapper, ML et al., Adrenal necrosis in the acquired immunodeficiency syndrome, Annals of Internal Medicine 1984, 100: 239-41.Google Scholar
Masur, H et al., Effect of 9-(1,3-dihydroxy-2-propoxymethyl) guanine on serious cytomegalovirus disease in eight immunosuppressed homosexual men, Annals of Internal Medicine 1986, 104: 41–44; Koretz, SH et al., Treatment of serious cytomegalovirus infection with 9-(1,3-dihydroxy-2-propoxymethyl) guanine in patients with AIDS and other immunodeficiencies, New England Journal of Medicine 1986, 314: 801-5.CrossRefGoogle ScholarPubMed
Mitsuyasu, RT, Groopman, JE, Biology and therapy for Kaposi's sarcoma, Seminars in Oncology 1984, 11: 53–59.Google ScholarPubMed
Mintzer, DM et al., Treatment of Kaposi's sarcoma and thrombocytopenia with vincristine in patients with the acquired immunodeficiency syndrome, Annals of Internal Medicine 1985, 102: 200–202.Google ScholarPubMed
Marmor, M et al., Risk factors for Kaposi's sarcoma in homosexual men, Lancet 1982, i: 1083–87.CrossRefGoogle Scholar
Drew, WL et al., Declining prevalence of Kaposi's sarcoma in homosexual AIDS patients is paralleled by declining incidence of CMV infection, in Program and abstracts of the 26th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, La., September 28–October 1, 1986.Google Scholar
Ziegler, JL et al., Non-Hodgkin's lymphoma in 90 homosexual men, New England Journal of Medicine 1984, 311: 565–70.Google ScholarPubMed
Ioachim, HC, Cooper, MC, Hellman, GC, Lymphomas in men at high risk for acquired immunodeficiency syndrome (AIDS): A study of 21 cases, Cancer 1985, 56: 2831–42.Google ScholarPubMed
Schoeppel, SC et al., Hodgkin's disease in homosexual men with generalized lymphadenopathy, Annals of Internal Medicine 1985, 102: 68–70.CrossRefGoogle ScholarPubMed
Snider, WD et al., Neurologic complications of acquired immunodeficiency syndrome: Analysis of 50 patients, Annals of Neurology 1983, 14: 403–18.Google ScholarPubMed
Navia, BA et al., The AIDS dementia complex II: Neuropathology, Annals of Neurology 1986, 19: 525–35; Epstein, LG et al., Progressive encephalopathy in children with acquired immunodeficiency syndrome, Annals of Neurology 1985, 17: 488-96.CrossRefGoogle ScholarPubMed
Parks, WP, Scott, GB, An overview of pediatric AIDS: Approaches to diagnosis and outcome assessment, Background paper, Washington, D.C.: Committee on a National Strategy for AIDS, 1986.Google Scholar
Marion, RW et al., Human T-cell lymphotropic virus type III (HTLV-III/LAV) embryopathy: A new dysmorphic syndrome associated with intrauterine HTLV-III infection, American Journal of Diseases in Children 1986, 140: 638–40.Google Scholar
Darrow, WW et al., Cofactors in the development of AIDS and AIDS-related conditions, in Program and abstracts of the Second International Conference on AIDS, Paris, France, June 23–25, 1986.Google Scholar
Coutinho, RA, The natural history of LAV/HTLV-III infection, in Program and abstracts of the Second International Conference on AIDS, Paris, France, June 23-25, 1986.Google Scholar
Katz, J, ed., The silent world of doctor and patient, New York: Free Press, 1984.Google Scholar
Gottlieb, MS, Fahey, JL, The clinical laboratory in the diagnosis and management of AIDS and HTLV-III/LAV infections, in Program and abstracts of the Second International Conference on AIDS, Paris, France, June 23-25, 1986.Google Scholar
Goudsmit, J et al., Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection, Lancet 1986, ii: 177–80.CrossRefGoogle Scholar
Lange, et al., supra note 3.Google Scholar
Dalgleish, AG et al., The CD4 (T4) antigen is an essential component antigen of the receptor for the AIDS retrovirus, Nature 1984, 312: 763–67.CrossRefGoogle ScholarPubMed
Hirsch, MS, Kaplan, JC, Prospects of therapy for infections with human T-lymphotropic virus type III, Annals of Internal Medicine 1985, 103: 750–55.CrossRefGoogle ScholarPubMed
Levine, AM et al., Suramin antiviral therapy in the acquired immunodeficiency syndrome: Clinical, immunologic, and virologic results, Annals of Internal Medicine 1985, 105: 32–37.CrossRefGoogle Scholar
Rozenbaum, W et al., Antimoniotungstate (HPA23) treatment of three patients with AIDS and one with prodrome, Lancet 1985, i: 450–51.CrossRefGoogle Scholar
Mitsuya, H, Broder, S, Inhibition of the in-vitro infectivity and cytopathic effect of HTLV-III/LAV by 2', 3'-dideoxynucleosides, Proceedings of the National Academy of Sciences USA 1986, 83: 1911–15; Yarchoan, R et al., Administration of 3'azido-3'-deoxythymidine, an inhibitor of HTLV-III replication, to patients with AIDS or AIDS-related complex, Lancet 1986, i: 575-80.Google ScholarPubMed
Mitsuya, et al., supra note 51.Google Scholar
McCormick, JB et al., Ribavirin suppresses replication of lymphadenopathy-associated virus in culture of human lymphocytes, Lancet 1984, ii: 1367–69; Roberts, RB et al., Effects of short term oral ribavirin in high risk patients for AIDS, in Program and abstracts of the Second International Conference on AIDS, Paris, June 23-25, 1986.Google Scholar
Sandstrom, EG et al., Inhibition of human T-cell lymphotropic virus type III in vitro by phosphonoformate, Lancet 1985, i: 1480–82.Google Scholar
Ho, D et al., Recombinant human interferon alfa-A suppresses HTLV-III replication in-vitro, Lancet 1985, i: 602–4.CrossRefGoogle Scholar
Grieco, HM et al., In-vivo immunomodulation by isoprinosine in patients with the acquired immunodeficiency syndrome and related complexes, Annals of Internal Medicine 1984, 101: 206–7; Tsang, PH et al., Modulation of T- and B-lymphocyte functions by isoprinosine in homosexual subjects with prodromata and in patients with acquired immune deficiency syndrome (AIDS), Journal of Clinical Microbiology 1984, 4: 49-78.Google ScholarPubMed
Lane, HC, Fauci, AS, Immunologic reconstitution in the acquired immunodeficiency syndrome, Annals of Internal Medicine 1985, 103: 714–18.Google ScholarPubMed
Bertram, JH et al., Protein A therapy with the Prosorba column in homosexual patients with idiopathic thrombocytopenic purpura-preliminary observations, in Program and abstracts of the Second International Conference on AIDS, Paris, June 23–25, 1986.Google Scholar
Mitsuyasu, et al., supra note 30.Google Scholar
Armstrong, D et al., Treatment of infections in patients with the acquired immunodeficiency syndrome, Annals of Internal Medicine 1985, 103: 738–43.CrossRefGoogle ScholarPubMed
Mayer, KH, HTLV-III screening and the blood supply: Public health policies and concerns, in Witt, MD, ed., AIDS: Legal, social and ethical considerations, Owings Mills, Md.: National Health Publishing, 1986, 35–39.Google Scholar
Mayer, KH, Testing for HTLV-III and AIDS risk reduction: Clinical and epidemiological quandaries, in Ostrow, D, ed., The bio-behavioral control of AIDS, New York: Irvington Press, in press.Google Scholar
Fox, R, Odaka, N, Polk, BF, Effect of learning HTLV-III/LAV antibody status on subsequent sexual activity, in Program and abstracts of the Second International Conference on AIDS, Paris, France, June 23-25, 1986.Google Scholar
Nation's hospitals awakening to increasing AIDS caseload, in Thornton, TG, ed., AIDS Alert 1986, 1: 117–20.Google Scholar
Id.Google Scholar